[1] Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice

[2] Clinical profile of serologically diagnosed pneumococcal pneumonia

[3] Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

[4] Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity

[5] The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

[6] Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

[7] In vitro and in vivo activities of anti-influenza virus compound T-705